Abstract:Furan and its derivatives are hazardous contaminants detected both in environmental objects and human biological media. The International Agency for Research on Cancer classifies furan as ‘possibly carcinogenic for humans’ (Group 2B). Upon inhalation, furan can induce lung edema and bronchi necrosis. An experiment that involved single oral administration of furan in corn oil 4 cm3/kg of Fischer 344 rat’s body weight established that furan at the dose of 0.1-0.2 mg/kg of body weight can oxidize into the toxic metabolite cis-2-butene-1 4-dial (BDA), which is an important trigger of toxic effects. The dose of 250 μg/kg of body weight induced chromosomal aberrations in male Fischer 344 rats. Furan is considered non-genotoxic hepatocarcinogen; it is metabolized in the liver to its metabolite cis-2-butene-1 4-dial (BDA), which is acutely toxic for liver cells. As a result, cell death is accompanied with tissue recovery and cell proliferation, which, in its turn, raises likelihood of carcinogenesis. The aim of this study was to study foreign experience, scientific-information sources and findings obtained by theoretical and experimental research, methods and methodologies for identifying mass concentrations of furan and its derivatives (furan and 2-methylfuran) in human biological media. The research object was represented by Russian and foreign scientific and methodical publications with their focus on toxic compounds of furan and its derivatives. We analyzed multiple literature sources available in Google scholar on methods and mythologies for identifying mass concentrations of furan and its derivatives in human biological media. Methodical documents valid in the Russian Federation were searched for on the following web-sites: http://www.normacs.ru; - https://files.stroyinf.ru. The analyzed period was equal to 37 years (from 1986 to 2023). The review provides in-depth description of physical and chemical methods employed to control levels of dioxin, furan and its derivatives in biological media; toxic and genetic effects; absorption, distribution, metabolism and excretion of furan from the body. It also covers toxicological properties of furan and its derivatives (animal experiments conducted on Fischer 344 mice and rats in EU countries and the USA). Conclusion. The review summarizes the experience gained by international studies in EU countries and the USA, which can be eligible for developing human biomonitoring and for implementation into practical activities as a sub-system within social and hygienic monitoring in the Russian Federation.

Validation of putative biomarkers of furan exposure through quantitative analysis of furan metabolites in urine of F344 rats exposed to stable isotope labeled furan

Rewiring cis-2-butene-1,4-dial mediated urinary metabolomics fingerprints of short-term exposure to furan

Dosimetry of human exposure to furan and 2-methylfuran by monitoring urinary biomarkers

Stable Isotope Dilution Analysis (SIDA) to Determine Metabolites of Furan and 2-Methylfuran in Human Urine Samples: A Pilot Study

Systematic establishment of the relationship between skin absorption and toxicity of furanoids via in silico, in vitro, and in vivo assessments

Adverse outcome pathway exploration of furan-induced liver fibrosis in rats: Genotoxicity pathway or oxidative stress pathway through CYP2E1 activation?

Comprehensive Profiling of Mercapturic Acid Metabolites from Dietary Acrylamide As Short-Term Exposure Biomarkers for Evaluation of Toxicokinetics in Rats and Daily Internal Exposure in Humans Using Isotope Dilution Ultra-High Performance Liquid Chromatography Tandem Mass Spectrometry.

Analysis of contemporary Russian and foreign approaches to biomonitoring of furan and its derivatives in the human body (literature review)

Understanding the Health Implications of Furan and Its Derivatives in Thermally Processed Foods: Occurrence, Toxicology, and Mixture Analysis

Determination of benchmark doses for linear furanocoumarin consumption associated with inhibition of cytochrome P450 1A2 isoenzyme activity in healthy human adults

Feature MS Fragments-Based Method for Identification of Toxic Furanoids in Biological Samples.

Targeted quantification and untargeted exploration of furan and derivatives in infant food by headspace extraction-gas chromatography-Q Exactive Orbitrap mass spectrometry

Development of a Sensitive and Quantitative Method for the Identification of Two Major Furan Fatty Acids in Human Plasma

Small Molecule Metabolite Biomarker Candidates In Urine From Mice Exposed To Formaldehyde

β'-Phenylfentanyl Metabolism in Primary Human Hepatocyte Incubations: Identification of Potential Biomarkers of Exposure in Clinical and Forensic Toxicology

Characterization of in Vivo and in Vitro Metabolites of Furanodiene in Rats by High Performance Liquid Chromatography-Electrospray Ionization Mass Spectrometry and Nuclear Magnetic Resonance Spectra

Genotoxic mode of action and threshold exploration of 2-methyl furan under 120-day sub-chronic exposure in male Sprague-Dawley rats

Toxicokinetics and Internal Exposure of Acrylamide: New Insight into Comprehensively Profiling Mercapturic Acid Metabolites As Short-Term Biomarkers in Rats and Chinese Adolescents.

Distribution of perfluoroalkyl compounds in rats: Indication for using hair as bioindicator of exposure

Rapid Simultaneous Determination of Cascade Metabolites of Acrylamide in Urine for Toxicokinetics Profiles and Short-Term Dietary Internal Exposure.

Metabolomics-based Biomarker Analysis of Dihydroxypropyl Mercapturic Acid Isomers from 3-Monochloropropane-1,2-diol and Glycidol for Evaluation of Toxicokinetics in Rats and Daily Internal Exposure in Humans